ArticleAmerican journal of translational research2025
Novel approaches to improve systemic bioavailability of curcumin using probiotics for rotenone-induced Parkinson's disease in rodents.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut Microbiome as a Source of Probiotic Drugs for Parkinson's Disease.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimThe prevalence of Parkinson's Disease (PD) is high, and treatment is not optimal to date. Curcumin possesses neuroprotective effects. Nevertheless, oral use is incommodious due to its poor bioavailability. Numerous attempts have been made to increase its systemic bioavailability. Among these, an effective way to increase the bioavailability of curcumin is by combining it with probiotics to target the glucuronidation reaction. The present study focuses on the bio-enhancement of curcumin using probiotics in animal models of PD by alleviating oxidative stress and ameliorating dopamine levels. MATERIALS AND
methodsForty-two male rats were used for the study. Twelve animals were used for a bio-availability study in which curcumin was administered orally alone and concomitantly with a probiotic ( RESULTS AND
conclusionsThe bioavailability study revealed a significant (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.